Overexpression of NFE2L3 or LASP1 could basically restore the effect of NAT10 knockdown on cell function, but not completely, which suggested that NAT10 might exert its influence on ccRCC by affecting other signalling pathways. The gene discussed is NAT10; the disease is nonpapillary renal cell carcinoma.